Published in Probl Tuberk on January 01, 1999
Red pigment of adenine-deficient yeast Saccharomyces cerevisiae. Biochem Biophys Res Commun (1967) 1.67
3 micron DNA - an extrachromosomal ribosomal DNA in the yeast Saccharomyces cerevisiae. Gene (1980) 1.07
The Saccharomyces cerevisiae ADE1 gene: structure, overexpression and possible regulation by general amino acid control. Gene (1991) 0.88
[Cytokine production-adenosine deaminase activity relationship in pulmonary tuberculosis]. Probl Tuberk (2000) 0.80
[Genetico-biochemical study of acid phosphatases in Saccharomyces cerevisiae yeast. V. Genetic control of regulation of acid phosphatase II synthesis]. Genetika (1975) 0.78
[Characteristics of prevention of tuberculosis in the conditions of low prevalence of tuberculous infection]. Probl Tuberk (1992) 0.77
A new diagnostic technique for adenylosuccinate lyase deficiency. J Inherit Metab Dis (1995) 0.76
[Isolation and properties of phosphoribosyl-aminoimidazole-succinocarboxyamide-synthestase from Saccharomyces cerevisiae yeasts]. Biokhimiia (1989) 0.75
[Genetic mapping of genes regulating synthesis of acid phosphatases in the yeast Saccharomyces cerevisiae of the Peterhoff yeast collection]. Genetika (1991) 0.75
[Vaccination against influenza in pulmonary tuberculosis patients]. Probl Tuberk (1980) 0.75
[Influenza vaccination of patients with pulmonary tuberculosis in the tuberculosis dispensary]. Probl Tuberk (1983) 0.75
[Immune status characteristics as the basis for the prognosis of lung diseases]. Probl Tuberk (1996) 0.75
[Evaluation of clinical significance of tuberculin sensitization in patients with lung cancer]. Probl Tuberk (1996) 0.75
[Current principles of diagnosis of cavitary formations in the lungs]. Probl Tuberk (1992) 0.75
[Changes in the production of interleukin-1 beta, tumor necrosis factor-alpha and interleukin-2 in relation to the immunity in patients with pulmonary tuberculosis]. Probl Tuberk (1999) 0.75
[Parameters of acquired immunity and cation proteins of neutrophilic granulocytes in pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2003) 0.75
[Distribution of histocompatibility antigens in patients with pulmonary tuberculosis depending on disease course and immune response pattern]. Probl Tuberk (1995) 0.75
[Outcomes of local interventions into the caverns in patients with destructive forms of postoperative recurrences of pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2003) 0.75
[Surgical treatment for postoperative recurrent pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Value of different combinations of immunological signs for differential diagnosis of lung diseases]. Probl Tuberk (1991) 0.75
[Study of the formation of antipulmonary autoantibodies in tuberculosis]. Probl Tuberk (1974) 0.75
[Use of immunofluorescent method in the identification of Mycobacteria]. Probl Tuberk (1978) 0.75
[Production of cytokines in different forms of pulmonary tuberculosis]. Probl Tuberk (1998) 0.75
[Differential approach to lymphadenectomy in patients with progressive fibrocavernous pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2009) 0.75
[Immunologic status of patients with pulmonary tuberculosis and pneumonia]. Probl Tuberk (1992) 0.75
[Early diagnosis of active pulmonary tuberculosis through isolation of a specific antigen in patients' blood]. Probl Tuberk (1975) 0.75
[Immunogenetic aspects of the course and treatment of pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.75
[Peculiarities of the circulating phagocytes functional activity in patients with different forms of drug-resistant pulmonary tuberculosis]. Biomed Khim (2013) 0.75
[Change in the corticotropin releasing activity of the rat hypothalamus at long intervals following irradiation]. Radiobiologiia (1976) 0.75
[Modification of the hemolysis test for isolation of antituberculosis antibodies]. Lab Delo (1975) 0.75
[A standardized highly sensitive variant of the complement fixation test for the detection of anti-tuberculosis antibodies]. Probl Tuberk (1986) 0.75
[Serological analysis of blood and cerebrospinal fluid in patients with meningeal tuberculosis]. Probl Tuberk (1991) 0.75
[The experience of applying of exogenous monoxide of nitrogen and argon plasma coagulation by cavernotomy in patients with fibro-cavernous pulmonary tuberculosis with the presence of multiple drug resistance]. Probl Tuberk Bolezn Legk (2008) 0.75
[Lymphocyte blast transformation reaction indices in the clinical picture of tuberculosis and their interrelationship with tuberculin tests and the synthesis of specific antibodies]. Probl Tuberk (1979) 0.75
[Immunological changes in patients with pulmonary tuberculosis during glutoxim therapy]. Probl Tuberk Bolezn Legk (2003) 0.75
[Immunological parameters in the assessment of the activity of a specific process in Mycobacterium tuberculosis-infected children and patients with intrathoracic lymphatic tuberculosis]. Probl Tuberk Bolezn Legk (2009) 0.75
[Diagnosis of liver diseases in patients with pulmonary tuberculosis]. Probl Tuberk (1992) 0.75
[Some regularities of an immune response in patients with pulmonary tuberculosis and drug-resistant Mycobacterium strains]. Probl Tuberk Bolezn Legk (2008) 0.75
[Significance of mycobacterial drug resistance in pulmonary tuberculosis surgery]. Probl Tuberk (2001) 0.75
[Molecular genetic characteristics of Mycobacterium tuberculosis isolated from patients operated on for pulmonary tuberculosis]. Probl Tuberk (2002) 0.75
[Informative value of diagnostic tables for detection of tuberculosis and related lung diseases]. Probl Tuberk (1990) 0.75
[Significance of immunologic testing of patients in surgery of pulmonary tuberculosis]. Probl Tuberk (1996) 0.75
[Characteristics of immunity in patients with destructive pulmonary tuberculosis]. Probl Tuberk (1992) 0.75
[Value of immunological indicators in the diagnosis of tuberculosis and nonspecific lung diseases]. Probl Tuberk (1985) 0.75
[External respiratory function and pulmonary capillary blood flow in patients with postoperative recurrent pulmonary tuberculosis]. Probl Tuberk (1999) 0.75
[Adjuvant lymphotrophic chemotherapy in the surgical treatment of progressive pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2009) 0.75
[Immunological parameters and mycobacterial biological properties in infiltrative pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2005) 0.75
[Complement consumption test as modified by A.A. Ivanov for determining the circulating antituberculous antibodies]. Probl Tuberk (1973) 0.75
[History of St. Petersburg Research Institute of Phthisiopulmonology, Ministry of Health of Russia]. Probl Tuberk Bolezn Legk (2003) 0.75
[Results of local intervention in the cavern in patients with destructive forms of postoperative relapses of pulmonary tuberculosis]. Probl Tuberk (2001) 0.75
[Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis]. Probl Tuberk (1988) 0.75
[Effect of various methods of immunotherapy on the immunological status of patients with pulmonary tuberculosis]. Probl Tuberk (1984) 0.75
[Tuberculin sensitization in patients with lung cancer]. Vopr Onkol (1994) 0.75
[Types of immunograms in new cases of pulmonary tuberculosis]. Probl Tuberk (1989) 0.75
[Value of serological studies for the characteristics of the course of tuberculosis]. Probl Tuberk (1978) 0.75
[Immune system and pathogenesis of tuberculosis]. Probl Tuberk (1995) 0.75
[Outcomes of surgical treatment of patients with progressive pulmonary tuberculosis an concomitant diseases]. Probl Tuberk Bolezn Legk (2005) 0.75
[Morphological features of fibro-cavernous pulmonary tuberculosis according to the surgical material]. Arkh Patol (2004) 0.75
[Long-term results of surgical treatment of pulmonary tuberculosis wtih respect to the extent of bacterial isolation and to drug resistance of Mycobacterium tuberculosis]. Probl Tuberk Bolezn Legk (2003) 0.75
[Thirty-five years' experience of thoracic surgery]. Probl Tuberk Bolezn Legk (2006) 0.75
[The diagnosis and treatment of acute pulmonary circulatory disorders after resection for tuberculosis]. Probl Tuberk Bolezn Legk (2005) 0.75
[Immunologic methods and their use for diagnosis in the treatment of pulmonary tuberculosis]. Probl Tuberk (1994) 0.75
[TREATMENT OF NON-SMALL CELL CARCINOMA OF LUNG IN SENILE PATIENTS]. Vestn Khir Im I I Grek (2015) 0.75
Synthesis of RNA and collagen by fibroblasts during connective tissue proliferation. Fed Proc Transl Suppl (1965) 0.75
[Immunological criteria in the differential diagnosis of lung diseases]. Probl Tuberk (1994) 0.75
[Pathological characteristics of drug-resistant fibrocavernous pulmonary tuberculosis]. Arkh Patol (2005) 0.75
[Surgical risk factors of complex polysegmental resections of lung for tuberculosis at multiple sites]. Probl Tuberk (1998) 0.75
[Forms of the specific immune response in tuberculosis and their relationship to the morphological characteristics of the process]. Probl Tuberk (1980) 0.75
[Immunity indicators and the degree of adenosine deaminase activity in patients with pulmonary tuberculosis]. Probl Tuberk (2002) 0.75
[Investigation of remaxol efficacy in complex therapy of experimental generalized tuberculosis on mice]. Antibiot Khimioter (2012) 0.75
[Late results of multistage polysegmental lung resection for tuberculosis at many sites]. Probl Tuberk (1998) 0.75
[Tuberculosis and pneumonia]. Probl Tuberk (1991) 0.75
[Assessment of a risk for postoperative infectious complications in patients with fibrocarvous pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2009) 0.75
[An experimental study of the efficiency of cycloferon in the complex chemotherapy of generalized drug-resistant tuberculosis]. Eksp Klin Farmakol (2012) 0.75
[Possibilities of computerized immunodiagnosis of tuberculosis and related lung diseases]. Probl Tuberk (1991) 0.75
[Estimation of the specific sensitization in a child and other immunological parameters in tuberculosis of intrathoracic lymph nodes during therapy]. Probl Tuberk Bolezn Legk (2007) 0.75
[Surgical treatment of multiple isolated intrapulmonary metastases]. Vestn Khir Im I I Grek (2014) 0.75
[Serologic method of diagnosing tuberculosis]. Probl Tuberk (1971) 0.75
[Correlation of specific immune response and tuberculous changes in the lungs]. Probl Tuberk (1993) 0.75
[Functional activity of phagocytes of bronchoalveolar lavage in patients with fibro-cavernosis and infiltrative pulmonary tuberculosis]. Biomed Khim (2007) 0.75
[The effect of tuberculin therapy on immunologic indicators in adolescents with pulmonary tuberculosis]. Probl Tuberk (1991) 0.75